by Dan Roberts (Updated 11/4/06) Drusen are thought to be fatty waste products from the photoreceptor cells. They often appear on the macula (the center of the retina) in the early stages of Macular Degeneration, and they can cause gradual loss of central vision. “Hard” drusen are common in aging eyes, and do not necessarily [Read More]
Category: Therapies, Treatments, and Procedures
Abortion Drug Offers Hope for People with Central Serous Chorioretinopathy
(Updated August 18, 2018) An abortion drug known as ru486 is showing potential as a treatment for central serous chorioretinopathy (CSC), a condition which can lead to loss of central vision. The drug, also called mifepristone, blocks the action of progesterone, a hormone necessary to sustain pregnancy. It is also a potent antiglucocorticoid agent. Glucocorticoids [Read More]
Biocurrent Therapy: A Promising Treatment for Dry AMD
by Dan Roberts with additional material by Wendy Strouse Watt, O.D. Originally Published October 26, 2005 Acuity Medical has successfully completed a proof of concept, double-masked trial of its TheraMac™ device for the treatment of dry age-related macular degeneration (AMD). The therapy developed from early studies of microcurrent stimulation, with improvements in the science and [Read More]
Photodynamic Therapy
by Dan Roberts Originally posted on MDSupport and updated in September 2005: QLT’s preliminary results found that Visudyne in an occult trial did not achieve its primary endpoint after two years. ———————————– Photodynamic therapy has been shown to be effective in helping to prevent further loss of sight in people who are afflicted by the [Read More]
Macular Translocation
by Dan Roberts Originally published July 2000 (Updated November 2003) Simply put, macular translocation is an experimental surgical procedure which involves detachment of the retina and relocation of it to a healthier spot in the eye. It has been described as “three to four hours of operating on something the size of a postage stamp [Read More]